Annual ROA
-101.27%
+1.44%+1.40%
31 December 2023
Summary:
Relmada Therapeutics annual return on assets is currently -101.27%, with the most recent change of +1.44% (+1.40%) on 31 December 2023. During the last 3 years, it has fallen by -50.96% (-101.29%). RLMD annual ROA is now -1346.71% below its all-time high of -7.00%, reached on 01 December 2019.RLMD ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROA
-112.06%
-16.23%-16.94%
30 September 2024
Summary:
Relmada Therapeutics quarterly return on assets is currently -112.06%, with the most recent change of -16.23% (-16.94%) on 30 September 2024. Over the past year, it has dropped by -26.18% (-30.48%). RLMD quarterly ROA is now -315.79% below its all-time high of 51.93%, reached on 30 September 2015.RLMD Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RLMD ROA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.4% | -30.5% |
| 3 y3 years | -101.3% | -5.9% |
| 5 y5 years | +40.2% | +60.8% |
RLMD ROA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -101.3% | +1.4% | -55.5% | at low |
| 5 y | 5 years | -1346.7% | +40.2% | -279.2% | +60.8% |
| alltime | all time | -1346.7% | +65.5% | -315.8% | +82.2% |
Relmada Therapeutics ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -112.06%(+16.9%) |
| June 2024 | - | -95.83%(+5.0%) |
| Mar 2024 | - | -91.30%(+7.3%) |
| Dec 2023 | -101.27%(-1.4%) | -85.11%(-0.9%) |
| Sept 2023 | - | -85.88%(-0.5%) |
| June 2023 | - | -86.33%(+3.9%) |
| Mar 2023 | - | -83.09%(+3.4%) |
| Dec 2022 | -102.71%(+82.4%) | -80.37%(+11.5%) |
| Sept 2022 | - | -72.05%(-13.1%) |
| June 2022 | - | -82.91%(-5.8%) |
| Mar 2022 | - | -88.06%(-7.4%) |
| Dec 2021 | -56.31%(+11.9%) | -95.11%(-10.1%) |
| Sept 2021 | - | -105.85%(+40.3%) |
| June 2021 | - | -75.42%(+28.1%) |
| Mar 2021 | - | -58.89%(+22.3%) |
| Dec 2020 | -50.31%(+618.7%) | -48.17%(+55.8%) |
| Sept 2020 | - | -30.91%(+4.6%) |
| June 2020 | - | -29.55%(-28.4%) |
| Mar 2020 | - | -41.29%(-85.6%) |
| Dec 2019 | -7.00%(-95.9%) | - |
| Sept 2019 | - | -285.88%(-27.0%) |
| June 2019 | -169.46% | -391.85%(-37.8%) |
| Mar 2019 | - | -629.90%(+17.2%) |
| Dec 2018 | - | -537.42%(+88.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2018 | - | -284.45%(+59.0%) |
| June 2018 | -293.98%(+32.7%) | -178.94%(+22.4%) |
| Mar 2018 | - | -146.21%(+16.5%) |
| Dec 2017 | - | -125.54%(+5.1%) |
| Sept 2017 | - | -119.44%(+0.5%) |
| June 2017 | -221.60%(+663.1%) | -118.87%(+6.5%) |
| Mar 2017 | - | -111.62%(+31.9%) |
| Dec 2016 | - | -84.60%(+8.3%) |
| Sept 2016 | - | -78.15%(+294.3%) |
| June 2016 | -29.04%(-66.0%) | -19.82%(-157.6%) |
| Mar 2016 | - | 34.42%(+32.9%) |
| Dec 2015 | - | 25.89%(-50.1%) |
| Sept 2015 | - | 51.93%(-170.4%) |
| June 2015 | -85.29%(+3.0%) | -73.72%(-19.0%) |
| Mar 2015 | - | -91.01%(-24.5%) |
| Dec 2014 | - | -120.62%(-62.5%) |
| Sept 2014 | - | -321.38%(-25.4%) |
| June 2014 | -82.81%(-64.7%) | - |
| Feb 2014 | - | -431.08%(+1.1%) |
| Nov 2013 | - | -426.53%(+26.2%) |
| Aug 2013 | -234.68%(+256.9%) | -337.89%(-9.2%) |
| May 2013 | - | -372.10%(+119.9%) |
| Feb 2013 | - | -169.23%(+51.2%) |
| Nov 2012 | - | -111.96%(+77.6%) |
| Aug 2012 | -65.76% | -63.04% |
FAQ
- What is Relmada Therapeutics annual return on assets?
- What is the all time high annual ROA for Relmada Therapeutics?
- What is Relmada Therapeutics annual ROA year-on-year change?
- What is Relmada Therapeutics quarterly return on assets?
- What is the all time high quarterly ROA for Relmada Therapeutics?
- What is Relmada Therapeutics quarterly ROA year-on-year change?
What is Relmada Therapeutics annual return on assets?
The current annual ROA of RLMD is -101.27%
What is the all time high annual ROA for Relmada Therapeutics?
Relmada Therapeutics all-time high annual return on assets is -7.00%
What is Relmada Therapeutics annual ROA year-on-year change?
Over the past year, RLMD annual return on assets has changed by +1.44% (+1.40%)
What is Relmada Therapeutics quarterly return on assets?
The current quarterly ROA of RLMD is -112.06%
What is the all time high quarterly ROA for Relmada Therapeutics?
Relmada Therapeutics all-time high quarterly return on assets is 51.93%
What is Relmada Therapeutics quarterly ROA year-on-year change?
Over the past year, RLMD quarterly return on assets has changed by -26.18% (-30.48%)